Search Results

Return to List
Results 1–20 of 90
Sort By: Relevance | Date | Title
1.

Microarrays and Next-Generation Sequencing Technology: The Use of Advanced Genetic Diagnostic Tools in Obstetrics and Gynecology

Committee Opinion Number 682, December 2016

(Replaces Committee Opinion Number 581, December 2013)

ABSTRACT Genetic technology has advanced dramatically in the past few decades and its applications and use in caring for and counseling pregnant women has been transformational in the realm of prenatal diagnosis Two of the newer genetic technologies in the prenatal setting are chromosomal microarr...

December 2016

PDF Format
2.

Disclosure and Discussion of Adverse Events

Committee Opinion Number 681, December 2016

(Replaces Committee Opinion No. 520, March 2012)

ABSTRACT Adverse outcomes preventable or otherwise are a reality of medical care Most importantly adverse events affect patients but they also affect health care practitioners Disclosing information about adverse events has benefits for the patient and the physician and ideally strengthens the pat...

December 2016

PDF Format
3.

The Use and Development of Checklists in Obstetrics and Gynecology

Committee Opinion Number 680, November 2016

ABSTRACT Checklists are used in medical and nonmedical settings as cognitive aids to ensure that users complete all the items associated with a particular task They are ideal for tasks with many steps for tasks performed under stressful circumstances or for reminding people to perform tasks that t...

November 2016

PDF Format
4.

Immersion in Water During Labor and Delivery

Committee Opinion Number 679, November 2016

(Replaces Committee Opinion Number 594, April 2014)

ABSTRACT Immersion in water during labor or delivery has been popularized over the past several decades The prevalence of this practice in the United States is uncertain because it has not been studied in births outside of the home and birth centers and the data are not recorded on birth certifica...

November 2016

PDF Format
5.

Antenatal Corticosteroid Therapy for Fetal Maturation

Committee Opinion Number 677, October 2016

ABSTRACT Corticosteroid administration before anticipated preterm birth is one of the most important antenatal therapies available to improve newborn outcomes A single course of corticosteroids is recommended for pregnant women between 24 07 weeks and 33 67 weeks of gestation including for those w...

October 2016

PDF Format
6.

Immediate Postpartum Long-Acting Reversible Contraception

Committee Opinion Number 670, August 2016

ABSTRACT Immediate postpartum longacting reversible contraception LARC has the potential to reduce unintended and shortinterval pregnancy Women should be counseled about all forms of postpartum contraception in a context that allows informed decision making Immediate postpartum LARC should be offe...

August 2016

PDF Format
7.

Hospital-Based Triage of Obstetric Patients

Committee Opinion Number 667, July 2016

ABSTRACT Emergency departments typically have structured triage guidelines for health care providers encountering the diverse cases that may present to their units Such guidelines aid in determining which patients must be evaluated promptly and which may wait safely and aid in determining anticipa...

July 2016

PDF Format
8.

Optimizing Postpartum Care

Committee Opinion Number 666, June 2016

ABSTRACT In the weeks after birth postpartum care often is fragmented among maternal and pediatric health care providers and communication between inpatient and outpatient settings is inconsistent To optimize postpartum care anticipatory guidance should begin during pregnancy During antenatal care...

June 2016

PDF Format
9.

Refusal of Medically Recommended Treatment During Pregnancy

Committee Opinion Number 664, June 2016

(Replaces Committee Opinion Number 321, November 2005)

ABSTRACT One of the most challenging scenarios in obstetric care occurs when a pregnant patient refuses recommended medical treatment that aims to support her wellbeing her fetuss wellbeing or both In such circumstances the obstetriciangynecologists ethical obligation to safeguard the pregnant wom...

June 2016

PDF Format
10.

Integrating Immunizations Into Practice

Committee Opinion Number 661, April 2016

ABSTRACT Immunization against vaccinepreventable diseases is an essential component of womens primary and preventive health care Despite the importance of vaccination and clear guidance from public health agencies rates of vaccination lag behind national goals Obstetriciangynecologists can play a ...

April 2016

PDF Format
11.

Family Building Through Gestational Surrogacy

Committee Opinion Number 660, March 2016

(Replaces Committee Opinion No. 397, February 2008)

ABSTRACT Gestational surrogacy is an increasingly common form of family building that can allow individuals or a couple to become parents despite circumstances in which carrying a pregnancy is biologically impossible or medically contraindicated The practice of gestational surrogacy involves a wom...

March 2016

PDF Format
12.

Magnesium Sulfate Use in Obstetrics

Committee Opinion Number 652, January 2016

(Reaffirmed 2016. Replaces Committee Opinion Number 573, September 2013)

ABSTRACT The US Food and Drug Administration advises against the use of magnesium sulfate injections for more than 57 days to stop preterm labor in pregnant women Based on this the drug classification was changed from Category A to Category D and the labeling was changed to include this new warnin...

January 2016

PDF Format
13.

Physical Activity and Exercise During Pregnancy and the Postpartum Period

Committee Opinion Number 650, December 2015

(Replaces Committee Opinion Number 267, January 2002)

ABSTRACT Physical activity in all stages of life maintains and improves cardiorespiratory fitness reduces the risk of obesity and associated comorbidities and results in greater longevity Physical activity in pregnancy has minimal risks and has been shown to benefit most women although some modifi...

December 2015

PDF Format
14.

Umbilical Cord Blood Banking

Committee Opinion Number 648, December 2015

(Replaces Committee Opinion Number 399, February 2008)

ABSTRACT Once considered a waste product that was discarded with the placenta umbilical cord blood is now known to contain potentially lifesaving hematopoietic stem cells When used in hematopoietic stem cell transplantation umbilical cord blood offers several distinct advantages over bone marrow o...

December 2015

PDF Format
15.

Dual Therapy for Gonococcal Infections

Committee Opinion Number 645, November 2015

ABSTRACT Gonorrhea is the second most commonly reported bacterial sexually transmitted disease in the United States with an estimated 820000 new Neisseria gonorrhoeae infections occurring each year Antimicrobial resistance limits treatment success heightens the risk of complications and may facili...

November 2015

PDF Format
16.

The Apgar Score

Committee Opinion Number 644, October 2015

(Replaces Committee Opinion Number 333, May 2006)

ABSTRACT The Apgar score provides an accepted and convenient method for reporting the status of the newborn infant immediately after birth and the response to resuscitation if needed The Apgar score alone cannot be considered to be evidence of or a consequence of asphyxia does not predict individu...

October 2015

PDF Format
17.

Identification and Referral of Maternal Genetic Conditions in Pregnancy

Committee Opinion Number 643, October 2015

ABSTRACT Advances in the understanding of genetic conditions reproductive technologies and improved medical and surgical care have enabled an increasing number of women with genetic conditions to achieve a normal pregnancy outcome However management of certain genetic conditions during pregnancy i...

October 2015

PDF Format
18.

Cell-free DNA Screening for Fetal Aneuploidy

Committee Opinion Number 640, September 2015

(This Committee Opinion Replaces Committee Opinion Number 545)

ABSTRACT Noninvasive prenatal screening that uses cellfree DNA from the plasma of pregnant women offers tremendous potential as a screening method for fetal aneuploidy A number of laboratories have validated different techniques for the use of cellfree DNA as a screening test for fetal aneuploidy ...

September 2015

PDF Format
19.

The Importance of Vital Records and Statistics for the Obstetrician-Gynecologist

Committee Opinion Number 639, September 2015

ABSTRACT Information from vital records is critical to identify and quantify healthrelated issues and to measure progress toward quality improvement and public health goals In particular maternal and infant mortality serve as important indicators of the nations health thereby influencing policy de...

September 2015

PDF Format
20.

First-Trimester Risk Assessment for Early-Onset Preeclampsia

Committee Opinion Number 638, September 2015

ABSTRACT Hypertensive disorders with adverse sequelae including preterm birth maternal morbidity and mortality and longterm risk of maternal cardiovascular disease complicate 510 of pregnancies Early identification of pregnant women at risk of developing earlyonset preeclampsia would theoretically...

September 2015

PDF Format

American Congress of Obstetricians and Gynecologists
409 12th Street SW, Washington, DC  20024-2188 | Mailing Address: PO Box 70620, Washington, DC 20024-9998